Erasca Inc (NASDAQ: ERAS) is -43.43% lower on its value in year-to-date trading and has touched a low of $1.23 and a high of $3.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ERAS stock was last observed hovering at around $1.32 in the last trading session, with the day’s gains setting it 0.1%.
Currently trading at $1.42, the stock is -4.98% and -26.49% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.62 million and changing 7.58% at the moment leaves the stock -43.31% off its SMA200. ERAS registered -44.31% loss for a year compared to 6-month loss of -50.87%.
The stock witnessed a -19.32% gain in the last 1 month and extending the period to 3 months gives it a -50.35%, and is 2.16% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.10% over the week and 8.71% over the month.
Erasca Inc (ERAS) has around 126 employees, a market worth around $401.47M and $0.00M in sales. Distance from 52-week low is 15.45% and -58.84% from its 52-week high. The company has generated returns on investments over the last 12 months (-31.92%).
The EPS is expected to grow by 12.21% this year
The shares outstanding are 282.69M, and float is at 163.45M with Short Float at 21.12%.
The top institutional shareholder in the company is VR ADVISER, LLC with over 16.22 million shares valued at $38.27 million. The investor’s holdings represent 7.4452 of the ERAS Shares outstanding. As of 2024-06-30, the second largest holder is FRAZIER LIFE SCIENCES MANAGEMENT, L.P. with 16.22 million shares valued at $38.27 million to account for 7.4452 of the shares outstanding. The other top investors are SUVRETTA CAPITAL MANAGEMENT, LLC which holds 13.77 million shares representing 6.3212 and valued at over $32.49 million, while ARCH VENTURE MANAGEMENT, LLC holds 5.0759 of the shares totaling 11.06 million with a market value of $26.09 million.
Erasca Inc (ERAS) Insider Activity
A total of 0 insider transactions have happened at Erasca Inc (ERAS) in the last six months, with sales accounting for 0 and purchases happening 0 times.
Still, SEC filings show that on Dec 16 ’24, Erasca Foundation (Affiliate) Proposed Sale 8,333 shares at an average price of $2.49 for $20787.0. The insider now directly holds shares of Erasca Inc (ERAS).
Erasca Inc (ERAS): Who are the competitors?
One of the company’s main competitors (and peers) include Eli Lilly & Co. (LLY) that is trading 19.23% up over the past 12 months.Johnson & Johnson (JNJ) lies in the list of competitors of the Erasca Inc and is 3.63% higher over the same period from ERASMerck & Co. Inc. (MRK) is -24.69% down on the 1-year trading charts.
